Cutaneous manifestations of systemic autoimmune rheumatic diseases including systemic sclerosis, idiopathic inflammatory myopathies, systemic lupus erythematosus, mixed connective tissue disease, Sjögren’s disease, and systemic vasculitis and the association with interstitial lung disease: a review of dermatologic risk stratification, screening and monitoring guidelines, and indications for pulmonary referral
Archives of Dermatological Research · 23.09.2026 · 318 (1)
DOI: 10.1007/s00403-026-04966-0 ↗Kurz gefasst
Leitlinie in der Zeitschrift Archives of Dermatological Research, online erschienen am 23.09.2026. Verfasst von Rachel M. Kirven und 8 weiteren Autor:innen. Die Arbeit nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Interstitial lung disease (ILD) significantly impacts morbidity in patients with systemic autoimmune rheumatic diseases associated with characteristic cutaneous manifestations, including systemic sclerosis, idiopathic inflammatory myopathies, systemic lupus erythematosus, mixed connective tissue disease, Sjögren’s disease, and systemic vasculitis. As early interstitial lung disease is often subclinical, a thorough understanding of extrapulmonary manifestations associated with ILD, particularly cutaneous findings, is essential for patient risk-stratification. Patients may seek care by a dermatologist early in their disease course, allowing the opportunity for prompt intervention. Dermatologists therefore play a critical role in accurately diagnosing systemic autoimmune rheumatic diseases to avoid delays in ILD screening with emerging opportunities to identify high-risk patients who warrant further evaluation. In this review, we highlight the appropriate clinical evaluation, evidence-based screening and monitoring guidelines, and indications for pulmonary referral in dermatologic patients with systemic autoimmune rheumatic diseases associated with ILD.
Zitieren
APA
Kirven, R. M., Bogunovich, K., Feibel, A. B., Amigo, M., Trovato, S., Massick, S. C., Allen, J., Ajam, A., & Bechtel, M. A. (2026). Cutaneous manifestations of systemic autoimmune rheumatic diseases including systemic sclerosis, idiopathic inflammatory myopathies, systemic lupus erythematosus, mixed connective tissue disease, Sjögren’s disease, and systemic vasculitis and the association with interstitial lung disease: a review of dermatologic risk stratification, screening and monitoring guidelines, and indications for pulmonary referral. Archives of Dermatological Research, 318(1). https://doi.org/10.1007/s00403-026-04966-0
Vancouver
Kirven RM, Bogunovich K, Feibel AB, Amigo M, Trovato S, Massick SC, et al. Cutaneous manifestations of systemic autoimmune rheumatic diseases including systemic sclerosis, idiopathic inflammatory myopathies, systemic lupus erythematosus, mixed connective tissue disease, Sjögren’s disease, and systemic vasculitis and the association with interstitial lung disease: a review of dermatologic risk stratification, screening and monitoring guidelines, and indications for pulmonary referral. Archives of Dermatological Research. 2026;318(1). doi:10.1007/s00403-026-04966-0
BibTeX
@article{Kirven2026,
author = {Kirven, Rachel M. and Bogunovich, Kirsten and Feibel, Annabelle B. and Amigo, Morgan and Trovato, Stephanie and Massick, Susan C. and Allen, James and Ajam, Ali and Bechtel, Mark A.},
title = {Cutaneous manifestations of systemic autoimmune rheumatic diseases including systemic sclerosis, idiopathic inflammatory myopathies, systemic lupus erythematosus, mixed connective tissue disease, Sjögren’s disease, and systemic vasculitis and the association with interstitial lung disease: a review of dermatologic risk stratification, screening and monitoring guidelines, and indications for pulmonary referral},
journal = {Archives of Dermatological Research},
year = {2026},
volume = {318},
number = {1},
doi = {10.1007/s00403-026-04966-0}
}
EUVIMED